Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/262673
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invite to open peer review
Title

Associations of salivary total antioxidant capacity with cortical amyloid-beta burden, cortical glucose uptake, and cognitive function in normal aging

AuthorsPalomar-Bonet, Miriam; Atienza, Mercedes; Hernández-Ledesma, Blanca CSIC ORCID ; Cantero, Jose L.
Issue Date2021
PublisherOxford University Press
CitationThe Journals of Gerontology: Series A 76(10): 1839–1845 (2021)
Abstract[Background]: Determining susceptibility to Alzheimer’s disease (AD) in asymptomatic individuals requires from noninvasive, simple, and inexpensive markers that can be easily obtained in primary care settings. While saliva meets all these requirements, there is a lack of evidence linking salivary constituents to in vivo AD pathology in aging.
[Methods]: We examined the potential of salivary total antioxidant capacity (TAC) for identifying global cortical amyloid-beta (Aβ) burden, deficits in regional glucose uptake, and poorer cognition in 71 cognitively normal older adults. We further assessed whether salivary TAC-related cognitive performance was associated with higher Aβ load and lower cortical glucose consumption.
[Results]: Linear regression analyses adjusted by age, sex, years of education, and ApoE4 status showed that salivary TAC was associated with slower processing speed and poorer sustained attention, as well as with higher Aβ load and lower glucose metabolism in cortical regions vulnerable to cognitive aging and AD. Results also revealed that lower scores in processing speed and sustained attention were associated with greater Aβ burden and lower regional glucose consumption, respectively.
[Conclusions]: Together, these findings support the use of salivary TAC for preventive screening and detection of cerebral vulnerability to AD. Further research is needed to evaluate the utility of salivary TAC as a clinical marker.
Publisher version (URL)https://doi.org/10.1093/gerona/glab034
URIhttp://hdl.handle.net/10261/262673
DOI10.1093/gerona/glab034
E-ISSN1758-535X
Appears in Collections:(CIAL) Artículos




Files in This Item:
File Description SizeFormat
Palomar-Bonet et al_manuscript_R1.pdf216,51 kBAdobe PDFThumbnail
View/Open
Show full item record

CORE Recommender

SCOPUSTM   
Citations

4
checked on May 24, 2024

WEB OF SCIENCETM
Citations

4
checked on Feb 23, 2024

Page view(s)

45
checked on May 28, 2024

Download(s)

160
checked on May 28, 2024

Google ScholarTM

Check

Altmetric

Altmetric


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.